InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-53.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Bartram Richard, Chief Financial Officer. Insider active across 1 company, notably Esperion Therapeutics, Inc.. In total, 2 reports have been recorded. History available since 29 October 2021. The latest transaction was filed on 14 March 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
37,000 shares0Common StockSEC:0001628280-22-006408:0
18,700 shares0Common StockSEC:0001628280-21-021008:0
2 of 2 declarations
About Bartram Richard
Richard Bartram is the Chief Financial Officer at Esperion Therapeutics, Inc. He is responsible for managing the company's finances, including accounting, financial planning, and financial reporting.
